LISATA THERAPEUTICS, INC. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Lisata Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • Lisata Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 12, 2024 was 8.39M shares, a 3.14% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 8.39M +255K +3.14% Nov 12, 2024 10-Q 2024-11-12
Q2 2024 8.32M +177K +2.18% Aug 12, 2024 10-Q 2024-08-12
Q1 2024 8.31M +309K +3.86% Feb 29, 2024 10-K 2024-02-29
Q3 2023 8.14M +280K +3.56% Nov 2, 2023 10-Q 2023-11-02
Q2 2023 8.14M -52.4M -86.6% Aug 14, 2023 10-Q 2023-08-14
Q1 2023 8M -52.5M -86.8% Mar 30, 2023 10-K 2023-03-30
Q3 2022 7.86M -51.9M -86.9% Nov 10, 2022 10-Q 2022-11-10
Q2 2022 60.6M +1.07M +1.79% Aug 4, 2022 10-Q 2022-08-04
Q1 2022 60.5M +1.03M +1.73% Mar 22, 2022 10-K 2022-03-22
Q3 2021 59.8M +40.4M +208% Nov 4, 2021 10-Q 2021-11-04
Q2 2021 59.5M +40.2M +208% Aug 5, 2021 10-Q 2021-08-05
Q1 2021 59.5M +48.9M +459% Feb 25, 2021 10-K 2021-02-25
Q3 2020 19.4M +9M +86.5% Nov 3, 2020 10-Q 2020-11-05
Q2 2020 19.3M +8.92M +85.8% Aug 13, 2020 10-Q 2020-08-13
Q1 2020 10.6M +688K +6.92% Mar 5, 2020 10-K 2020-03-05
Q3 2019 10.4M +558K +5.67% Nov 5, 2019 10-Q 2019-11-06
Q2 2019 10.4M +676K +6.95% Aug 8, 2019 10-Q 2019-08-08
Q1 2019 9.95M +398K +4.17% Mar 8, 2019 10-K 2019-03-14
Q3 2018 9.84M +371K +3.92% Nov 7, 2018 10-Q 2018-11-08
Q2 2018 9.73M +813K +9.12% Aug 7, 2018 10-Q 2018-08-09
Q1 2018 9.55M +1.24M +15% Mar 22, 2018 10-K 2018-03-22
Q3 2017 9.47M +1.3M +15.9% Nov 9, 2017 10-Q 2017-11-09
Q2 2017 8.91M +3M +50.7% Aug 8, 2017 10-Q 2017-08-10
Q1 2017 8.31M -50.7M -85.9% Mar 16, 2017 10-K 2017-03-17
Q3 2016 8.17M -47.2M -85.2% Nov 1, 2016 10-Q 2016-11-07
Q2 2016 5.91M -49.4M -89.3% Aug 5, 2016 10-Q 2016-08-09
Q1 2016 59M +20.6M +53.5% Mar 14, 2016 10-K 2016-03-15
Q3 2015 55.4M +19.6M +54.9% Nov 4, 2015 10-Q 2015-11-05
Q2 2015 55.3M +20.1M +57% Aug 4, 2015 10-Q 2015-08-06
Q1 2015 38.5M +9.88M +34.6% Feb 27, 2015 10-K 2015-03-02
Q3 2014 35.7M +8.6M +31.7% Oct 30, 2014 10-Q 2014-10-30
Q2 2014 35.3M +14.9M +73.5% Aug 7, 2014 10-Q 2014-08-07
Q1 2014 28.6M -140M -83% Mar 11, 2014 10-K 2014-03-13
Q3 2013 27.1M -132M -83% Nov 6, 2013 10-Q 2013-11-07
Q2 2013 20.3M -132M -86.7% Aug 8, 2013 10-Q 2013-08-08
Q1 2013 168M +54.1M +47.3% Mar 8, 2013 10-K 2013-03-11
Q3 2012 159M +52.1M +48.5% Nov 13, 2012 10-Q 2012-11-13
Q2 2012 153M +54.5M +55.6% Aug 10, 2012 10-Q 2012-08-14
Q1 2012 114M Mar 12, 2012 8-K 2012-08-15
Q3 2011 107M Nov 8, 2011 10-Q 2011-11-10
Q2 2011 98M Aug 10, 2011 10-Q 2011-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.